Topic: Insys Therapeutics

DEA finalizing Schedule II status for synthetic THC drug Syndros

• Pharma CEO who funded anti-cannabis campaign accused of giving docs kickbacks to prescribe opioids
• New Jersey sues painkiller company, calling its methods “evil”
• Synthetic THC drug Syndros poised for Schedule II classification
• The non-weed biz world is zeroing in on legalization
• A casino magnate’s spending millions against pot. Here’s who’s also donating for (and against) legalization
• Biz owners replace idealists in pro-pot movement
• Is a maker of deadly painkillers bankrolling the opposition of Arizona marijuana legalization?